These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7987978)

  • 21. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.
    Peters WP; Eder JP; Henner WD; Schryber S; Wilmore D; Finberg R; Schoenfeld D; Bast R; Gargone B; Antman K
    J Clin Oncol; 1986 May; 4(5):646-54. PubMed ID: 3517240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bis-chloronitrosourea (BCNU) on pulmonary and serum angiotensin converting enzyme activity in rats.
    Smith AC; Boyd MR
    Biochem Pharmacol; 1983 Dec; 32(24):3719-22. PubMed ID: 6318769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia.
    Zander AR; Vellekoop L; Spitzer G; Verma DS; Litam J; McCredie KB; Keating M; Hester JP; Dicke KA
    Cancer Treat Rep; 1981; 65(5-6):377-81. PubMed ID: 7016323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
    Teicher BA; Herman TS; Hopkins RE; Menon K
    J Cancer Res Clin Oncol; 1992; 118(2):123-8. PubMed ID: 1735732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
    Helal GK; Helal OK
    Arch Toxicol; 2009 Jan; 83(1):87-94. PubMed ID: 18528683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
    Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy study for remission maintenance in ALL: an evaluation of vincristine, cyclophosphamide and vincristine, cyclophosphamide, and BCNU: a Southwest Oncology Group Phase II Study.
    Sexauer CL; Vietti T; Humphrey GB
    Am J Pediatr Hematol Oncol; 1981; 3(3):255-7. PubMed ID: 6945060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
    Bearman SI; Overmoyer BA; Bolwell BJ; Taylor CW; Shpall EJ; Cagnoni PJ; Mechling BE; Ronk B; Barón AE; Purdy MH; Ross M; Jones RB
    Bone Marrow Transplant; 1997 Dec; 20(11):931-7. PubMed ID: 9422471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies.
    Alessandrino EP; Bernasconi P; Colombo A; Caldera D; Martinelli G; Vitulo P; Malcovati L; Nascimbene C; Varettoni M; Volpini E; Klersy C; Bernasconi C
    Bone Marrow Transplant; 2000 Feb; 25(3):309-13. PubMed ID: 10673703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of N-acetylcysteine against carmustine-induced myelotoxicity in rats.
    El-Sayed el-SM; Abdel-Aziz AA; Helal GK; Saleh S; Saad AS
    Food Chem Toxicol; 2010 Jun; 48(6):1576-80. PubMed ID: 20332008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemosensitivity spectrum of a human pleural mesothelioma xenograft grown in athymic rats.
    Lindén CJ
    In Vivo; 1991; 5(4):375-80. PubMed ID: 1810423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
    Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
    Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
    Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
    Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoprotective effects of trimetazidine in carmustine cholestasis.
    Girgin F; Tüzün S; Demir A; Kuralay F; Ozutemiz O; Tanyalcin T
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):326-9. PubMed ID: 10445391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carmustine infusion reactions are more common with rapid administration.
    Janson B; Van Koeverden P; Yip SW; Thakerar A; Mellor JD
    Support Care Cancer; 2012 Oct; 20(10):2531-5. PubMed ID: 22252549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kehrer JP; Klein-Szanto AJ
    Cancer Res; 1985 Nov; 45(11 Pt 2):5707-13. PubMed ID: 4053044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.